留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

青葙总皂苷对高血脂动物脂质代谢的影响

吴文丹,  梁琳,  唐颖,  倪海莱,  郭美丽

downloadPDF
文章导航 > 药学实践与服务  > 2018 >  36(6): 493-498
吴文丹, 梁琳, 唐颖, 倪海莱, 郭美丽. 青葙总皂苷对高血脂动物脂质代谢的影响[J]. 药学实践与服务, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
引用本文: 吴文丹, 梁琳, 唐颖, 倪海莱, 郭美丽. 青葙总皂苷对高血脂动物脂质代谢的影响[J]. 药学实践与服务, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
shu
WU Wendan, LIANG Lin, TANG Ying, NI Hailai, GUO Meili. Pharmacodynamic study of total celosins on anti-hyperlipidemia[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
Citation: WU Wendan, LIANG Lin, TANG Ying, NI Hailai, GUO Meili. Pharmacodynamic study of total celosins on anti-hyperlipidemia[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
shu

青葙总皂苷对高血脂动物脂质代谢的影响

doi: 10.3969/j.issn.1006-0111.2018.06.004
  • 1.

    第二军医大学药学院生药学教研室, 上海 200433

  • 2.

    第二军医大学附属长海医院预防保健科, 上海 200433

基金项目: 上海市中药现代化专项（11DZ1970501）

Pharmacodynamic study of total celosins on anti-hyperlipidemia

  • 1.

    Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 2.

    Department of Preventive Health Care, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

  • 摘要: 目的 探讨青葙总皂苷（CES）对高血脂动物脂质代谢的影响。 方法 建立金黄地鼠、家兔高血脂模型，对实验动物血液和肝组织脂质指标和脂质过氧化指标进行检测，并对动物肝脏进行病理组织学观察。 结果 经口给予CES 10~90 mg/kg两周，可降低高血脂金黄地鼠血清和肝脏组织中血清总胆固醇（TC），甘油三酯（TG）和低密度脂蛋白胆固醇（LDL-c）含量（P<0.05或P<0.01）；经口给予高血脂家兔CES 6~24.0 mg/kg，给药10 d时，可降低血清TC和LDL-c含量（P<0.01）；给药20 d和30 d，不仅降低了血清TC、LDL-c含量（P<0.01），还降低了TG含量（P<0.05），表现出作用持续时间长而平稳的特点。同时，CES还可降低肝脏组织中TC、TG含量（P<0.05）和丙二醛（MDA）、血清脂肪酶（LPS）含量（P<0.05）。病理组织学观察显示：家兔模型组肝细胞胞浆内脂肪堆积明显，肝细胞受损程度严重，有大面积点状坏死现象。随着CES给药剂量的增加，肝细胞胞浆内脂肪堆积明显减少，肝细胞受损程度也明显减轻。 结论 CES对动物高血脂脂代谢紊乱有明显治疗作用，其对高血脂脂代谢紊乱的治疗作用可能与其降低肝组织中MDA和LPS的含量有关。
    Abstract: Objective To study the effect of total saponin (CES) on lipid metabolism in hyperlipidemic animals. Methods Golden hamster and rabbit hyperlipidemia animal models were established for this study.Both hyperlipidemia models were achieved by feeding high fat diet. The blood, hepatic lipid parameters and lipid peroxidation index were detected.Liver pathological changes were recorded. Results CES were orally administered to golden hamster hyperlipidemia model for two weeks at doses of 10-90 mg/kg. TC, TG and LDL-c were significantly reduced both in the serum and liver.In rabbit hyperlipidemia model, CES was orally administered at 6.0-24.0 mg/kg. Serum TC and LDL-c were reduced at day 10.Significant reduction of serum TC, LDL-c levels (P<0.01) and TG content (P<0.05) were observed after 20 and 30 days.This lipid-lowing effect was long lasting and stable. At the meantime, CES can also decrease the liver tissue TC, TG content (P<0.05) and MDA, LPS content (P<0.05). Pathological section showed that fat was significantly accumulated in the liver cell cytoplasm in rabbit model group. The liver cells were damaged. Large area of spotty necrosis was observed. Fat accumulation in the cytoplasm was significantly decreased in CES groups with dose dependent manner. With increased CES dose, liver damage was ameliorated. Conclusion CES can effectively reduce lipids in different animal hyperlipidemia models. This effect may be related to the decrease of the content of MDA and LPS in liver.
  • [1] Orsó E, Ahrens N, Kilálic D, et al. Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors[J]. Atheroscler Suppl, 2009, 10(5):74-78.
    [2] Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood[J]. Pediatrics, 2008, 122(1):198-208.
    [3] Michaelson J, Hariharan V, Huang H. Hyperglycemic and hyperlipidemic conditions alter cardiac cell biomechanical properties[J]. Biophys J, 2014, 106(11):2322-2329.
    [4] Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia[J]. N Engl J Med, 1988, 319(18):1222-1223.
    [5] 中国科学院植物志编委会, 中国植物志, 第25(2)卷[M].北京:科学出版社1979:200.
    [6] 国家药典委员会. 中华人民共和国药典(2010版)[M]. 北京:中国医药科技出版社, 2010:184.
    [7] Hase K, Kadota S, Basnet P, et al. Hepatoprotective effects of traditional medicine. Isolation of the active constituents from seeds of celosia argentea[J].Phytother Res, 1996, 10(5):387-392.
    [8] Hase K, Kadota S, BasnetP, et al. Protective effect of celosian, an acidic polysaccharide, on chemically and immunologically induced liver injuries[J]. Biol Pharm Bull. 1996, 19(4):567-572.
    [9] Hase K, Basnet P, Kadota S, et al. Immunostimulating activity of celosian, an antihepatotoxic polysaccharide isolated from celosia argentea[J]. Planta Med. 1997, 63(3):216-219.
    [10] Devhare SV, Nirmal SA, Rub RA, et al.Immunomodulating activity of celosia argentea Linn Aerial Parts[J].Lat Am J Pharm, 2011, 30(1):168-171.
    [11] Wu QB, WangY, GuoML. Triterpenoidsaponins from the seeds of celosia argentea and their anti-inflammatory and antitumor activities[J].Chem Pharm Bull. 2011, 59(5):666-671.
    [12] Vetrichelvan T, Jegadeesan M, Devi BA. Anti-diabetic activity of alcoholic extract of celosia argentea Linn. seeds in rats[J]. Biol Pharm Bull, 2002, 25(4):526-528.
    [13] 单俊杰, 任晋玮, 杨静, 等. 青葙子提取物降血糖活性的研究[J]. 中国药学杂志,2005, 40(16):1230-1233.
    [14] 黄秀榕, 祁明信, 汪朝勇, 等. 4种归肝经明目中药对晶状体上皮细胞凋亡相关基因Bcl-2和Bax的调控[J]. 中国临床药理学与治疗学, 2004,9(3):322-325.
    [15] 黄秀榕, 祁明信, 汪朝勇, 等. 四种归肝经明目中药防护晶状体氧化损伤和上皮细胞调亡的研究[J]. 中国临床药理学与治疗学, 2004,9(4):441-446.
    [16] Xue Q, Sun ZL, Guo ML, et al. Two new compounds from Semen celosiae and their protective effects against CCl4-induced hepatotoxicity[J]. Nat Prod Res, 2011, 25(8):772-780.
    [17] Sun ZL, Wang Y, Guo ML, et al. Two new hepaprotective saponins from Semen celosiae[J]. Fitoterapia, 2010, 81(5):375-380.
    [18] Wu QB, Wang Y, Liang L, et al. Novel triterpenoid saponins from the seeds of celosia argentea L[J]. Nat Prod Res, 2013, 27(15):1353-1360.
    [19] Chen RB, Zhang YY, He JM, et al. Simultaneous determination of two major triterpenoid saponins:Celosins I and Ⅱ in Celosiae Semen by HPLC-ELSD[J]. Chinese Herbal Medicines, 2015, 7(2):185-190.
    [20] 唐颖,梁琳,郭美丽. 青葙总皂苷对肝损伤保护作用的研究[J]. 药学实践杂志,2016. 34(3):201-205.
    [21] 高莹, 李可基, 唐世英, 等. 几种高脂血症动物模型的比较[J]. 卫生研究, 2002,31(2):97-99.
    [22] Xing WW, Wu JZ, Jia M, et al. Effects of polydatin from polygonum cuspidatum on lipid profile in hyperlipidemic rabbits[J]. Biomedecine&pharmacotherapie, 2009, 63(7):457-462.
  • [1] 景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞.  黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
    [2] 毛智毅, 王筱燕, 陈晓颖, 汤逸斐.  度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
    [3] 王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉.  全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3437
  • HTML全文浏览量:  443
  • PDF下载量:  821
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-03-29
  • 修回日期:  2018-06-20

青葙总皂苷对高血脂动物脂质代谢的影响

doi: 10.3969/j.issn.1006-0111.2018.06.004
  • 1. 第二军医大学药学院生药学教研室, 上海 200433
  • 2. 第二军医大学附属长海医院预防保健科, 上海 200433
    • 基金项目:  上海市中药现代化专项（11DZ1970501）
  • 收稿日期: 2018-03-29
  • 修回日期: 2018-06-20

摘要: 目的 探讨青葙总皂苷（CES）对高血脂动物脂质代谢的影响。 方法 建立金黄地鼠、家兔高血脂模型，对实验动物血液和肝组织脂质指标和脂质过氧化指标进行检测，并对动物肝脏进行病理组织学观察。 结果 经口给予CES 10~90 mg/kg两周，可降低高血脂金黄地鼠血清和肝脏组织中血清总胆固醇（TC），甘油三酯（TG）和低密度脂蛋白胆固醇（LDL-c）含量（P<0.05或P<0.01）；经口给予高血脂家兔CES 6~24.0 mg/kg，给药10 d时，可降低血清TC和LDL-c含量（P<0.01）；给药20 d和30 d，不仅降低了血清TC、LDL-c含量（P<0.01），还降低了TG含量（P<0.05），表现出作用持续时间长而平稳的特点。同时，CES还可降低肝脏组织中TC、TG含量（P<0.05）和丙二醛（MDA）、血清脂肪酶（LPS）含量（P<0.05）。病理组织学观察显示：家兔模型组肝细胞胞浆内脂肪堆积明显，肝细胞受损程度严重，有大面积点状坏死现象。随着CES给药剂量的增加，肝细胞胞浆内脂肪堆积明显减少，肝细胞受损程度也明显减轻。 结论 CES对动物高血脂脂代谢紊乱有明显治疗作用，其对高血脂脂代谢紊乱的治疗作用可能与其降低肝组织中MDA和LPS的含量有关。

English Abstract

吴文丹, 梁琳, 唐颖, 倪海莱, 郭美丽. 青葙总皂苷对高血脂动物脂质代谢的影响[J]. 药学实践与服务, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
引用本文: 吴文丹, 梁琳, 唐颖, 倪海莱, 郭美丽. 青葙总皂苷对高血脂动物脂质代谢的影响[J]. 药学实践与服务, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
shu
WU Wendan, LIANG Lin, TANG Ying, NI Hailai, GUO Meili. Pharmacodynamic study of total celosins on anti-hyperlipidemia[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
Citation: WU Wendan, LIANG Lin, TANG Ying, NI Hailai, GUO Meili. Pharmacodynamic study of total celosins on anti-hyperlipidemia[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(6): 493-498. doi: 10.3969/j.issn.1006-0111.2018.06.004
shu

    全文HTML

参考文献 (22)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计